Ignite Creation Date:
2024-05-06 @ 12:29 PM
Last Modification Date:
2024-10-26 @ 1:00 PM
Study NCT ID:
NCT03778619
Status:
UNKNOWN
Last Update Posted:
2020-07-28
First Post:
2018-11-07
Brief Title:
MG4101 Plus Rituximab Including Lymphodepletion in Patient With rr NHL B-cell Origin
Sponsor:
GC Cell Corporation
Organization:
GC Cell Corporation
Organization Data
Organization:
GC Cell Corporation
Class:
INDUSTRY
Study ID:
MG4101-NHL-P1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
GC Cell Corporation
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None